The Demant Group develops, manufactures and sells products and equipment that help people with hearing loss connect and communicate with the world around them. The company operates a focused hearing healthcare company, consisting of three business areas: Hearing Aids, Hearing Care, and Diagnostics. The Hearing Aids business area engages in the development, manufacturing, and wholesale of hearing aids, developing innovative and leading technological solutions that create life-changing hearing health. The Hearing Care business area comprises the Audika Group, which is a global retail company that provides personalized hearing care to customers worldwide through several strong local brands. The Diagnostics business area consists of a group of international companies and is the global market leader in hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics worldwide. In 2024, the company launched a new supplier engagement program to collect primary data and set targets for suppliers to enhance their environmental performance. Additionally, Demant introduced the Oticon Intent™, the world’s first hearing aid with user-intent sensors, and launched the Encanta hearing aids with a focus on the individual user under the Bernafon brand. Interacoustics introduced the Aided Cortical test to help infants with hearing loss hear better.

The Demant Group serves customers in over 130 countries through its Hearing Aids business area, which includes more than 900 employees in Hearing Aids R&D. The Hearing Care business area operates over 4,000 clinics worldwide and provides hearing care clinics in more than 25 countries. The Diagnostics business area facilitates the screening of over 200 million people and holds a market-leading position in relevant categories. In 2024, Demant acquired a Danish chain of hearing care clinics, Dansk HøreCenter, expanding its market presence.

The total revenue for 2024 is 22,419 million DKK. The revenue is not explicitly broken down by ESRS sectors in the provided images.

Our PURPOSE is to create life-changing differences through hearing health. Our AMBITION is as the leading hearing healthcare company to improve as many lives as possible. Our PRIORITISATION is to support the entire journey to better hearing by focusing on personalised care and innovative solutions. Our COMMITMENT includes delivering a world-class customer and user experience that exceeds expectations, pursuing an engaging, inclusive and innovative work culture, enabling employees to develop and grow, and driving attractive financial returns and growth based on a resilient business model. Our CHOICES and ENABLERS support sustainable growth, including innovation and core technology development, consolidation of distribution, growth across geographies and channels, and responsible and sustainable business practices.

The Demant Group develops, manufactures and sells products and equipment that help people with hearing loss connect and communicate with the world around them. The business areas include Hearing Aids, Hearing Care, and Diagnostics. Hearing Aids serve customers in 130+ countries with innovative solutions. Hearing Care operates 4,000+ clinics worldwide. Diagnostics facilitates screening of 200+ million people. Sustainability-related goals include supplier engagement to enhance environmental performance and a 16% emissions reduction in transportation for Diagnostics in 2024.

Our strategy focuses on creating value by growing our business at a rate exceeding the market growth rate, while improving profitability through economies of scale and efficiency. Key elements include fuel innovation and core technology development, participate in consolidation of distribution and leverage commercial position, grow across geographies and channels and in adjacent business activities, leverage scalability and increase business resilience, and drive responsible and sustainable business practices. We are committed to adding value responsibly and sustainably, aligning with the purpose and ambition of the company.

Our operating model is designed to steer us in operating our three business areas – Hearing Aids, Hearing Care and Diagnostics – in a setup that is ensuring that we remain focused on excelling in each business area, while leveraging synergies across the Group through strong collaboration. This approach enables each business area to adopt a customer-centric approach and execute their specific strategic initiatives to deliver on the strategy, enabling the Group to create life-changing solutions that complement each other. Our operating model is founded on a robust internal infrastructure, encompassing IT, HR, finance, sustainability as well as legal systems and processes. This strong backbone, which we call Group Services, supports business growth, ensures efficiency and enables economies of scale in a sustainable and responsible way.

Input includes employing 22,000+ people, more than DKK 1.4 billion invested annually in R&D, a growing portfolio of 3,500+ patents and designs, a global distribution network with over 4,000 hearing care clinics, and strong relationships with component suppliers. Our business areas' common understanding of technology and innovation is at the core of our operating model. We focus on value-adding collaboration between the R&D functions of our individual business areas, ensuring supply chain agility and resilience.

Output includes diagnostic equipment that increases the quality of patient care, high-quality hearing aid solutions, and personal and individualised treatment offering the highest level of expertise in audiology. Outcome involves creating life-changing differences through hearing health by helping people overcome hearing loss and improving their lives supported by innovative solutions and hearing care. Customers benefit from a user experience that exceeds expectations, employees work in an inclusive environment, and investors receive attractive financial returns and growth based on a resilient business model.

The upstream value chain includes raw materials purchase by suppliers, component manufacturing, transport, research & development, and production and service of products. The downstream value chain involves marketing and sales, product use, transport, and external customers. Diagnostic equipment and hearing aids reach own hearing care professionals, external customers, and users through retail, product use, and transport. The organization operates a long and complex value chain, engaging with suppliers that operate in countries and industries with potentially negative impacts on workers’ rights.